Effects of morphine on the dyspnea of terminal cancer patients.

  title={Effects of morphine on the dyspnea of terminal cancer patients.},
  author={Eduardo Bruera and K Macmillan and J M Pither and Robert N. MacDonald},
  journal={Journal of pain and symptom management},
  volume={5 6},
We report an open, uncontrolled study designed to assess the effects of subcutaneous (SC) morphine on dyspnea of terminal cancer. Twenty patients with dyspnea caused by restrictive respiratory failure received an SC dose of morphine of 5 mg (5 patients who were not receiving narcotics), or equivalent to 2.5 times their regular dose (15 patients who were receiving narcotics for pain). Dyspnea (D) and pain (15 cases) were measured before the dose and every 15 min for 150 min after the injection… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 34 extracted citations

Service delivery of complex interventions for refractory breathlessness.

Current opinion in supportive and palliative care • 2016
View 1 Excerpt

Similar Papers

Loading similar papers…